Contact Us
  Search
The Business Research Company Logo
Global Urinary Incontinence Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Urinary Incontinence Market Report 2026

Global Outlook – By Type (Urge Incontinence, Stress Incontinence, Overflow Incontinence, Functional Incontinence), By Treatment Type (Medication, Devices, Other Treatments), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Diagnosis (Physical Exam, Pad Test, Urodynamic Testing, Cystoscopy, Stress Test, Ultrasound, Urine Samples), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035

Urinary Incontinence Market Overview

• Urinary Incontinence market size has reached to $13.33 billion in 2025 • Expected to grow to $18.84 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Rising Prevalence Of Urological Disorders Propelling Growth In The Urinary Incontinence Market • Market Trend: Pioneering Patient Care With An Advanced Smart Urinary Sphincter In Urinary Incontinence Treatment • North America was the largest region in 2025.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Urinary Incontinence Market?

Urinary incontinence is a medical condition characterized by the unintentional loss of urine, ranging from occasional leaks to a complete inability to control urination. Weakened pelvic floor muscles, hormonal changes, obesity, neurological conditions, urinary tract infections, medications and pregnancy can cause urinary incontinence. The main types of urinary incontinence are urging incontinence, stress incontinence, overflow incontinence and functional incontinence. Urge incontinence, also known as overactive bladder, is characterized by a sudden and strong urge to urinate that is difficult to control which is managed through medications that help calm and control the bladder muscles, behavioral techniques such as bladder training and lifestyle modifications. Treatments such as medication, devices and others are administered orally, parenterally and through other routes to treat urinary incontinence. Treatment and diagnostic tools and services such as physical exams, pad tests, urodynamic testing, cystoscopy, stress tests, ultrasound and urine samples are provided by end users, including hospitals, specialty clinics, homecare and others.
Urinary Incontinence Market Global Report 2026 Market Report bar graph

What Is The Urinary Incontinence Market Size and Share 2026?

The urinary incontinence market size has grown strongly in recent years. It will grow from $13.33 billion in 2025 to $14.2 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing aging population, rising prevalence of obesity-related conditions, higher incidence of childbirth-related pelvic disorders, improved access to diagnostic healthcare services, growing awareness of urinary health disorders.

What Is The Urinary Incontinence Market Growth Forecast?

The urinary incontinence market size is expected to see strong growth in the next few years. It will grow to $18.84 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to expansion of personalized treatment approaches, rising adoption of digital health monitoring tools, growing demand for non-surgical therapies, increasing focus on preventive urological care, advancements in incontinence treatment devices. Major trends in the forecast period include increasing adoption of advanced diagnostic methods, rising demand for minimally invasive treatment options, growing focus on pelvic floor rehabilitation therapies, expansion of home-based incontinence management solutions, enhanced awareness of urinary health conditions.

Global Urinary Incontinence Market Segmentation

1) By Type: Urge Incontinence, Stress Incontinence, Overflow Incontinence, Functional Incontinence 2) By Treatment Type: Medication, Devices, Other Treatments 3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration 4) By Diagnosis: Physical Exam, Pad Test, Urodynamic Testing, Cystoscopy, Stress Test, Ultrasound, Urine Samples 5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users Subsegments: 1) By Urge Incontinence: Overactive Bladder, Urinary Urgency 2) By Stress Incontinence: Involuntary Leakage During Physical Activity, Coughing Or Sneezing 3) By Overflow Incontinence: Chronic Urinary Retention, Frequent Or Constant Dribbling 4) By Functional Incontinence: Cognitive Impairment, Physical Limitations

What Is The Driver Of The Urinary Incontinence Market?

The increase in the prevalence of urological disorders is expected to propel the growth of the urinary incontinence market going forward. Urological disorders refer to medical conditions that affect the urinary system and male reproductive organs, including the kidneys, bladder, ureters, urethra, prostate, and testes. The prevalence of urological disorders is increasing due to rising disease burden driven by aging populations and lifestyle-related health changes. The urinary incontinence market supports this trend by providing diagnostic tools, therapeutic products, and advanced treatment solutions that address growing patient needs. For instance, in January 2023, according to the American Cancer Society, a US-based voluntary cancer awareness organization, the estimated number of urinary bladder cancer cases reached 82,290 in 2023, reflecting an increase compared to recent years as disease burden continues to grow. Therefore, the increase in the prevalence of urological disorders will drive the growth of the urinary incontinence industry.

Key Players In The Global Urinary Incontinence Market

Major companies operating in the urinary incontinence market are Teleflex Incorporated, Ethicon Inc., Laborie Medical Technologies Corp., NeoTract Inc., Promedon GmbH, Caldera Medical Inc, Cook Medical Inc, Cook Group Inc, ConvaTec Group PLC, Boston Scientific Corporation, Coloplast A/S, B Braun Melsungen AG, Medtronic plc, Hollister Incorporated, Becton Dickinson and Company, A.M.I. GmbH, Atlantic Therapeutics Group Ltd, InControl Medical, Zephyr Surgical Implants

What Are Latest Mergers And Acquisitions In The Urinary Incontinence Market?

In September 2023, Amber Therapeutics, a UK-based medtech company, acquired Bioinduction Limited for an disclosed amount. As a result of this acquisition, Amber gained the Picostim DyNeuMo neuromodulation therapy platform. Amber is now using this advanced implantable system to deliver closed-loop therapy specifically designed for mixed urinary incontinence, known as Amber-UI. Bioinduction Limited is a UK-based medical device company specializing in neuromodulation devices for urinary incontinence.

Regional Outlook

North America was the largest region in the urinary incontinence market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Urinary Incontinence Market?

The urinary incontinence market includes revenues earned by entities by providing medical diagnosis and evaluation, medication and surgical interventions, pelvic floor muscle training and physical therapy, behavioral therapies and bladder training and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The urinary incontinence market also includes sales of electrical stimulation devices, foley catheters, antimicrobial foley catheters and urethral bulking agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Urinary Incontinence Market Report 2026?

The urinary incontinence market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the urinary incontinence industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Urinary Incontinence Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$14.2 billion
Revenue Forecast In 2035$18.84 billion
Growth RateCAGR of 6.6% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredType, Treatment Type, Route Of Administration, Diagnosis, End-Users
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledTeleflex Incorporated, Ethicon Inc., Laborie Medical Technologies Corp., NeoTract Inc., Promedon GmbH, Caldera Medical Inc, Cook Medical Inc, Cook Group Inc, ConvaTec Group PLC, Boston Scientific Corporation, Coloplast A/S, B Braun Melsungen AG, Medtronic plc, Hollister Incorporated, Becton Dickinson and Company, A.M.I. GmbH, Atlantic Therapeutics Group Ltd, InControl Medical, Zephyr Surgical Implants
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us